Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Acute Undifferentiated Leukemia

Ayman Qasrawi, MD, Gomez Victor, MD, Reinhold Munker, MD

Blood (2019) 134 (Supplement_1): 3847.

https://doi.org/10.1182/blood-2019-123274

Published: 2019

Journal Articles

Disparities in Plasma Cell Neoplasms in Kentucky, Appalachia and Other States: A Population Based Study

Ayman Qasrawi, MD, Richard L O'Neal, MD, Maxwell M. Krem, MD PhD, Gregory Monohan, MD, Reinhold Munker, MD, Gerhard C. Hildebrandt, MD

Blood (2019) 134 (Supplement_1): 4735.

https://doi.org/10.1182/blood-2019-127687

Published: 2019

Journal Articles

Autoimmune Hemolytic Anemia and Checkpoint Inhibitors: 68 Cases from the FDA Database and Critical Review

Georges Tanios, MD, Peter B Doley, Reinhold Munker, MD

Blood (2018) 132 (Supplement 1): 2324.

https://doi.org/10.1182/blood-2018-99-111724

Published: 2018

Journal Articles

Long-Term Outcomes of Autologous Hematopoietic Cell Transplantation Using Melphalan and Total Body Irradiation Conditioning in Multiple Myeloma

Ali Baghian, MD, Reinhold Munker, MD, Yordanka Koleva, MPH, Gunita Matharoo, MPH, Patricia Andrews, MPH, Ato Wright, MD PhD, Nakhle S. Saba, MD, Hana Safah, MD

Blood (2016) 128 (22): 4644.

https://doi.org/10.1182/blood.V128.22.4644.4644

Published: 2016

Journal Articles

Concomitant Acute Promyelocytic Leukemia and Chronic Lymphocytic Leukemia: Molecularly Two Distinct Diseases

Jingdong Su, MD, Hazem E. El-Osta, MD, Reinhold Munker, MD, Glenn M. Mills, MD, Srinivas S. Devarakonda, MD

Blood (2015) 126 (23): 4904.

https://doi.org/10.1182/blood.V126.23.4904.4904

Published: 2015

Journal Articles

Potent Inhibition of the Growth and Induction of Apoptosis in Lymphoma By the Anthelminthic Drug Niclosamide: In Vitro Data

Junaid Ansari, MD, Paula Polk, Jeffrey Aufman, MD, Guillermo A Herrera, MD, James Cardelli, PhD, Reinhold Munker, MD

Blood (2015) 126 (23): 5131.

https://doi.org/10.1182/blood.V126.23.5131.5131

Published: 2015

Journal Articles

Acute Myelogenous Leukemia: Insurance Status, Race and Comorbidities, but Not Distance from Treatment Center Determine Outcome

Samip Master, MD, Zhenzhen Shi, Srinivas S. Devarakonda, MD, Reinhold Munker, MD, Runhua Shi, MDPhDMPH

Blood (2015) 126 (23): 3283.

https://doi.org/10.1182/blood.V126.23.3283.3283

Published: 2015

Journal Articles

Is Interim/Mid-Treatment PET (interim PET, i-PET) Scan Predictive of Outcome in Diffuse Large B-Cell Lymphoma?.

Dushyant Verma, MD, FACP, Amol Takalkar, MD, Runhua Shi, MD, PhD, Glenn M. Mills, MD, FACP, Srikanth Paladugu, MD, Diana Veillon, MD, Reinhold Munker, MD, Gerhard Hildebrandt, MD, Binu S. Nair, MD, FACP, Nebu Koshy, MD, FACP

Blood (2012) 120 (21): 2675.

https://doi.org/10.1182/blood.V120.21.2675.2675

Published: 2012

Journal Articles

BH3 Profiling Predicts 5-Azacytidine Response in Malignant Myeloid Cells

James M Bogenberger, PhD, William E. Pierceall, PhD, Ryan Lena, BS, Reinhold Munker, MD, Kaoru Tohyama, MD, PhD, Lisa Sproat, MD, MSW, Pierre Noel, MD, Jose F. Leis, MD, PhD, James L Slack, MD, Ruben A. Mesa, Michael Cardone, PhD, Raoul Tibes, MD, PhD

Blood (2012) 120 (21): 1432.

https://doi.org/10.1182/blood.V120.21.1432.1432

Published: 2012

Journal Articles

Regulation of Selected MicroRNAs in Multiple Myeloma,

Reinhold Munker, MD, Tetsuro Setoyama, MD, Madeleine Duvic, MD, Robert Z. Orlowski, MD, PhD, George Calin, MD PhD

Blood (2011) 118 (21): 3916.

https://doi.org/10.1182/blood.V118.21.3916.3916

Published: 2011

Journal Articles

Activity of Tyrosine Kinase Inhibitors in Multiple Myeloma.

Reinhold Munker, MD, Cory Cordova, BS, Paula Polk, BS, Charles V. Wendling, MD, Amanda W. Sun, MD PhD, James A. Cardelli, PhD

Blood (2007) 110 (11): 4804.

https://doi.org/10.1182/blood.V110.11.4804.4804

Published: 2007

Journal Articles

Characterization of Gene Expression Associated with Cyclophosphamide Resistance in Chronic Myeloid Leukemia (CML).

Fei Bao, MD, Mary L. Nordberg, PhD, Paula Polk, MS, Amanda Sun, MD, PhD, David Murray, PhD, Borje S. Andersson, MD, PhD, Reinhold Munker, MD

Blood (2005) 106 (11): 1532.

https://doi.org/10.1182/blood.V106.11.1532.1532

Published: 2005

NARROW

Acute Undifferentiated Leukemia

Disparities in Plasma Cell Neoplasms in Kentucky, Appalachia and Other States: A Population Based Study

Autoimmune Hemolytic Anemia and Checkpoint Inhibitors: 68 Cases from the FDA Database and Critical Review

Long-Term Outcomes of Autologous Hematopoietic Cell Transplantation Using Melphalan and Total Body Irradiation Conditioning in Multiple Myeloma

Concomitant Acute Promyelocytic Leukemia and Chronic Lymphocytic Leukemia: Molecularly Two Distinct Diseases

Potent Inhibition of the Growth and Induction of Apoptosis in Lymphoma By the Anthelminthic Drug Niclosamide: In Vitro Data

Acute Myelogenous Leukemia: Insurance Status, Race and Comorbidities, but Not Distance from Treatment Center Determine Outcome

Is Interim/Mid-Treatment PET (interim PET, i-PET) Scan Predictive of Outcome in Diffuse Large B-Cell Lymphoma?.

BH3 Profiling Predicts 5-Azacytidine Response in Malignant Myeloid Cells

Regulation of Selected MicroRNAs in Multiple Myeloma,

Activity of Tyrosine Kinase Inhibitors in Multiple Myeloma.

Characterization of Gene Expression Associated with Cyclophosphamide Resistance in Chronic Myeloid Leukemia (CML).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only